chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: Histamine intolerance, Urticaria
Clinical narrative: 2nd Vaccine infected me with horrible large hives with high Histamine Intolerance; 2nd Vaccine infected me with horrible large hives with high Histamine Intolerance; This spontaneous case was reported by a patient and describes the occurrence of HISTAMINE INTOLERANCE (2nd Vaccine infected me with horrible large hives with high Histamine Intolerance) and URTICARIA (2nd Vaccine infected me with horrible large hives with high Histamine Intolerance) in a female patient of an unknown age who received mRNA-1273 (Spikevax) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. In April 2022, the patient experienced HISTAMINE INTOLERANCE (2nd Vaccine infected me with horrible large hives with high Histamine Intolerance) and URTICARIA (2nd Vaccine infected me with horrible large hives with high Histamine Intolerance). At the time of the report, HISTAMINE INTOLERANCE (2nd Vaccine infected me with horrible large hives with high Histamine Intolerance) and URTICARIA (2nd Vaccine infected me with horrible large hives with high Histamine Intolerance) had not resolved.            No concomitant product use was reported.  The patient stated Covid-19 moderna 2nd vaccine infected patient with horrible large hives with high histamine Intolerance. The patient had it since 3 months and it was getting worst. The patient never had allergies before.  The patient was going to the doctor, but the medications are not helping. The patient contacted the CDC.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Hair disorder, Pruritus, Skin test, Thyroid disorder
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of PRURITUS (itching from waist up), HAIR DISORDER (something in his hair follicles) and THYROID DISORDER (thyroid due to some findings in his blood works within the last month) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 083J21A, 003B21A, 041B21A and 039D21A) for COVID-19 prophylaxis. The patient's past medical history included Non-Hodgkin's lymphoma (for which patient had 2 sets of chemotherapy). Previously administered products included for Product used for unknown indication: Flu vaccine in September 2021. Past adverse reactions to the above products included No adverse event with Flu vaccine. Concurrent medical conditions included AFib, Blood pressure high (now maintained) and Cholesterol (now maintained). Concomitant products included APIXABAN (ELIQUIS), METOPROLOL and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication. On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 04-Apr-2022, received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching from waist up), HAIR DISORDER (something in his hair follicles) and THYROID DISORDER (thyroid due to some findings in his blood works within the last month). The patient was treated with TRIAMCINOLONE (topical) at an unspecified dose and frequency; DOXYCYCLINE at an unspecified dose and frequency and LEVOTHYROXINE at an unspecified dose and frequency. At the time of the report, PRURITUS (itching from waist up), HAIR DISORDER (something in his hair follicles) and THYROID DISORDER (thyroid due to some findings in his blood works within the last month) had not resolved. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Skin test: there is no lymphoma now. For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments. It was reported that he applies Triamcinolone 1% Cream every day on different sites. He was also on Doxycycline for a month currently midway as his dermatologist thought there must be something in his hair follicles. He stated that these medications were not helping. He was also started on Levothyroxine for his thyroid due to some findings in his blood works within the last month.
Sex: U
Vaccine: IPV
Symptoms: Medication error, No adverse event, Poor quality product administered, Product storage error
Clinical narrative: vaccines were given post excursion  with no adverse event; The excursion lasted for 1 hour and 5 minutes. The minimum temperature of the refrigerator reached 27.5 degrees Fahrenheit with no reported adverse event; Initial information received on 07-Jul-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves an unknown age and  gender patient who was vaccine given post excursion with no adverse event and the excursion lasted for 1 hour and 5 minutes. the minimum temperature of the refrigerator reached 27.5 degrees fahrenheit with no reported adverse event, while receiving vaccine IPV (VERO) [IPOL].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a  dose of suspect IPV (VERO) (lot C5843AD and  expiration date: 25-Oct-2023) at an unknown dose via unknown route in unknown administration site for immunization.  On 24-Jun-2022,  the reporter stated that temperature excursion due to leaving the door ajar for the refrigerator. The excursion lasted for 1 hour and 5 minutes. The minimum temperature of the refrigerator reached 27.5 degrees Fahrenheit (product storage error) (unknown latency) and the vaccines were administered post excursion  with no adverse event (poor quality product administered)(latency: same day) .  Action taken :not applicable.  It was not reported if the patient received a corrective treatment for the events   At time of reporting, the outcome was Unknown for both events .  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  01180094:
Age: 56.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: No adverse event, Vaccination error
Clinical narrative: she gave MENACTRA and BEXSERO in the same syringe to a patient with no reported adverse event; Initial information received on 08-Jul-2022 regarding an unsolicited valid  non-serious case received from a physician.  This case involves a 56 years old female patient and reported stated that she gave BEXSERO and MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] in the same syringe to a patient with no reported adverse event.   The patient's past medical history, medical treatment(s),concomitant medication,  vaccination(s) and family history were not provided.   On 06-Jul-2022, the patient received 0.5 ml 1X (once) dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (Formulation was unknown, lot U726BAB and expiry date: 22-Apr-2023) via intramuscular route in right deltoid for Immunization On an unknown date, the patient received an unknown dose of suspect BEXSERO not produced by Sanofi Pasteur (Formulation, lot number and expiry date was unknown) via unknown route in unknown administration site for Prophylactic vaccination.  On 06-Jul-2022 the patient developed a non-serious event of she gave menactra and bexsero in the same syringe to a patient with no reported adverse event (multiple use of single-use product) following the administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE and (unknown latency) following the administration of BEXSERO.  Action taken : not applicable.  Outcome: Unknown  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: UNK, YF
Symptoms: No adverse event, Wrong product administered
Clinical narrative: received a dose of saline instead of the yellow fever vaccine with no reported adverse event; Initial information received on 11-Jul-2022 regarding an unsolicited valid  non-serious case received from a physician.  This case involves an unknown age and unknown gender patient who received a dose of SALINE [SODIUM CHLORIDE] instead of the YELLOW FEVER VACCINE - [YF-VAX] vaccine with no reported adverse event.   The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided.    On an unknown date, the patient took SALINE [SODIUM CHLORIDE] with unknown dose (with an unknown strength, formulation, frequency, batch number and expiry date) for unknown indication. On an unknown date, the patient received a dose of suspect YELLOW FEVER VACCINE - (with an unknown strength, formulation, frequency, batch number and expiry date) via unknown route in unknown administration site for Immunization.  On an unknown date the patient developed a non-serious event of received a dose of saline instead of the yellow fever vaccine with no reported adverse event (wrong product administered) (latency: unknown).   Action taken: not applicable.   Outcome: Unknown     This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: UNK, YF
Symptoms: No adverse event, Wrong product administered
Clinical narrative: received a dose of saline instead of the yellow fever vaccine with no reported adverse event; Initial information received on 11-Jul-2022 regarding an unsolicited valid non-serious case received from a physician. GMI number: 01184725  This case involves an unknown age and unknown gender patient who experienced received a dose of SALINE [SODIUM CHLORIDE] instead of the YELLOW FEVER VACCINE - [YF-VAX] vaccine with no reported adverse event.   The patient's past medical history, medical treatment(s), concomitant medication, vaccination(s) and family history were not provided. This case is linked to cases 2022SA279048, 2022SA276277 and 2022SA278093.    On an unknown date, the patient took Saline [Sodium Chloride] at (unknown: strength, formulation, dose, frequency, batch number and expiry date) for unknown indication. On an unknown date, the patient received a dose of suspect YELLOW FEVER VACCINE - (with an unknown strength, formulation, frequency, batch number and expiry date) via unknown route in unknown administration site for Immunization.  On an unknown date, the patient developed a non-serious event of received a dose of saline instead of the yellow fever vaccine with no reported adverse event (wrong product administered) (latency: unknown).   Action taken: Not applicable.  Outcome: Unknown    This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 16.0
Sex: M
Vaccine: MNQ, MNQ
Symptoms: Extra dose administered, No adverse event
Clinical narrative: MENQUADFI vaccination was given along with Menevo vaccine by mistake, with no adverse event.; Initial information was received on 12-Jul-2022 regarding an unsolicited valid non-serious case received from other health professional via call center.   This case involves a 16 years old male patient who experienced menquadfi vaccination was given along with menevo vaccine by mistake, with no adverse event while receiving vaccines MENINGOCOCCAL VACCINE A/C/Y/W CONJ (CRM197) [MENVEO] and meningococcal A-C-Y-W135 (T CONJ) vaccine [MENQUADFI].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On 12-Jul-2022, the patient received a  dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE (lot U6823AA) (dose, formulation, strength and expiry date: unknown) via intramuscular route in the left deltoid for immunization.    On 12-Jul-2022, the patient received a  dose of suspect MENVEO not produced by Sanofi Pasteur lot number (dose, formulation, strength, lot and expiry date: unknown) via unknown route in unknown administration site for immunization.    On 12-JUL-2022 the patient developed a non-serious menquadfi vaccination was given along with menevo vaccine by mistake, with no adverse event (extra dose administered) (latency same day) following the administration of menveo and menquadfi.   Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event menquadfi vaccination was given along with menevo vaccine by mistake, with no adverse event. .  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.25
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered, Medication error, No adverse event
Clinical narrative: administered an expired PENTACEL to a 15-month-old patient with no reported adverse event; Initial information received on 12-Jul-2022 regarding an unsolicited valid non-serious case received from other health professional.  This case involves a 15 months old male patient who was administered with expired Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine [Pentacel] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Pneumococcal Vaccine Conj 13V (CRM197) (Prevnar 13) for prophylactic vaccination (immunization).  On 12-Jul-2022, the patient received a 0.5 ml dose (4th dose) once total of suspect Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine Suspension for injection (lot: UJ473AAA; expiry date: 09Jul2022; strength not reported) via intramuscular route in the left thigh for prophylactic vaccination (immunization).  On 12-Jul-2022 the patient developed a non-serious event administered an expired pentacel to a 15-month-old patient with no reported adverse event (expired product administered) (latency: same day) following the administration of Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine.  Action taken with Diphtheria/Tetanus/5 Hybrid AC Pertussis/IPV(MRC5)/HIB(PRP/T) Vaccine (Pentacel) was not applicable.  It was not reported if the patient received a corrective treatment for the event.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 13.0
Sex: F
Vaccine: MNQ
Symptoms: No adverse event, Product storage error
Clinical narrative: Temperature excursion with lowest temperature of 0.17 degree Celsius for 9 days with no reported adverse event; Menquadfi has been administered post excursion (lowest temperature reached 0.17 C and the total excursion lasted 9 days) with no reported adverse event; Initial information received on 12-Jul-2022 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves a 13 years old female patient who was administered meningococcal A-C-Y-W135 (T conj) vaccine [Menquadfi] post excursion (lowest temperature reached 0.17 degree Celsius and the total excursion lasted 9 days) with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included HPV vaccine VLP RL1 4V (yeast) (Gardasil); and diphtheria vaccine toxoid, pertussis vaccine acellular 3-component, tetanus vaccine toxoid (Boostrix).  On an unknown date the suspect meningococcal A-C-Y-W135 (T conj) vaccine was exposed to a temperature excursion with lowest temperature of 0.17 degree Celsius for 9 days with no reported adverse event (product storage error).  On 08-Jul-2022, the patient received a dose of suspect meningococcal A-C-Y-W135 (T conj) vaccine (lot U7249AA, expiry date: 11-Mar-2024; formulation, strength and dose not reported) via intramuscular route in the right deltoid for immunization.  On 08-Jul-2022, the patient was administered meningococcal A-C-Y-W135 (T conj) vaccine post excursion (lowest temperature reached 0.17 degree Celsius and the total excursion lasted 9 days) with no reported adverse event (poor quality product administered) (latency: same day).  Action taken was not applicable.  Outcome: Unknown for both the events   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. ; Sender's Comments:  01187328:
Sex: F
Vaccine: HIBV
Symptoms: Medication error, Wrong product administered
Clinical narrative: received a pediatric vaccine with no reported adverse event; Initial information received on 13-Jul-2022 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp.  This case involves a 25 years old female patient who received a pediatric vaccine with no reported adverse event , and it involved vaccine HIB (PRP/T) VACCINE [ACT-HIB].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On 01-Jun-2022, the patient received a 0.5 ml dose of suspect HIB (PRP/T) VACCINE, once, ( lot: UJ581AAA ; expiry date: 17-Sep-2022)  via intramuscular route in unknown administration site for immunization. It was reported that patient was supposed to receive TD from Sanofi but her medical record stated that she received Tetanus IG TG. However, doctor office stated that they had no Tetanus IGTG and the patient received pediatric vaccine instead (wrong product administered) (onset date: 01-Jun-022; latency: same day).  Action taken : not applicable.  Outcome: unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 18.0
Sex: M
Vaccine: MENB
Symptoms: Inappropriate schedule of product administration, No adverse event
Clinical narrative: 1st vaccine 6/23/2022 and 2nd dose 2 weeks later; This case was reported by a consumer via call center representative and described the occurrence of drug dose administration interval too short in a 18-year-old male patient who received Men B NVS (Bexsero) for prophylaxis.   Co-suspect products included meningococcal B recom vaccine + aloh + omv pre-filled syringe device (Bexsero Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concomitant products included MENINGOCOCCAL B VACCINE (BEXSERO).   On 11th July 2022, the patient received the 2nd dose of Bexsero .5 ml and Bexsero Pre-Filled Syringe Device. On 11th July 2022, unknown after receiving Bexsero and Bexsero Pre-Filled Syringe Device, the patient experienced drug dose administration interval too short. On an unknown date, the outcome of the drug dose administration interval too short was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional Information: GSK Receipt Date: 11-July-2022. Reporter's Comments: The patient's mother stated that patient got his first Bexsero vaccine on 23rd June 2022 and second dose 2 weeks later versus the one month as stated in the prescribing information. No side effects were reported.  The reporter consented to follow-up. Additional Supportive Information: The patient received Bexsero vaccine before the recommended one month interval, which led to drug dose administration interval too short.
Age: 82.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site hypoaesthesia, Injection site paraesthesia, Sleep disorder
Clinical narrative: arm tingle, bothers her at night; arm numbness, bothers her at night; This case was reported by a consumer via call center representative and described the occurrence of injection site paresthesia in a 82-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 9th June 2022, the patient received the 1st dose of Shingrix (intramuscular). On 11th June 2022, 2 days after receiving Shingrix, the patient experienced injection site paresthesia and injection site numbness. On an unknown date, the outcome of the injection site paresthesia and injection site numbness were not recovered/not resolved.   It was unknown if the reporter considered the injection site paresthesia and injection site numbness to be related to Shingrix.     Additional Information: GSK Receipt Date: 11-JUL-2022 Reporter's Comments: The case was self-reported by the patient. The patient received first dose of Shingrix vaccine into left deltoid and two days later left arm began to tingle with numbness. The patient hoped it goes away soon because it bothers her at night when she was trying to sleep. The reporter did not consent to follow up with her and her healthcare professional.
Age: 52.0
Sex: F
Vaccine: VARZOS
Symptoms: Psoriasis
Clinical narrative: psoriasis plaque; This case was reported by a pharmacist via call center representative and described the occurrence of psoriatic plaque in a 52-year-old female patient who received Herpes zoster (Shingrix) (batch number l24m5, expiry date 1st July 2023) for prophylaxis.   On 1st April 2022, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, less than 4 months after receiving Shingrix, the patient experienced psoriatic plaque. On an unknown date, the outcome of the psoriatic plaque was not recovered/not resolved.   It was unknown if the reporter considered the psoriatic plaque to be related to Shingrix.     Additional Information: GSK Receipt Date: 12-JUL-2022 Reporter's comment: The patient experienced a psoriasis plaque on her arm after getting her dose of Shingrix vaccine. The patient stated that the plaque was small and had been slowly growing. The reporter did not consent to follow-up.
Sex: U
Vaccine: VARZOS
Symptoms: Inappropriate schedule of product administration
Clinical narrative: received 1st dose in 2020 and more than a year later 2nd.; This case was reported by a nurse via call center representative and described the occurrence of drug dose administration interval too long in a patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose in 2020).   On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced drug dose administration interval too long. On an unknown date, the outcome of the drug dose administration interval too long was unknown.   Additional Information: GSK Receipt Date: 12-JUL-2022 Reporter's Comments: The nurse reported that the patient just received second dose of Shingrix somewhere and also mentioned that it was more than a year from first dose. The reporter consented to follow up. The reporter did not want to answer any safety question. No further information available.  Additional Supportive Information: The patient received the second dose later than the recommended interval, which led to lengthening of vaccination schedule.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. Other Case identifier(s): 22K-163-4359071-00 (AbbVie). A 66-year-old female patient received BNT162b2 (BNT162B2), on 12Feb2021 as dose 1, single (Batch/Lot number: unknown), on 11Mar2021 as dose 2, single (Batch/Lot number: unknown) and on 11Aug2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 65 years, all intramuscular for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "caught covid after getting booster". The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Age: 60.0
Sex: M
Vaccine: TD
Symptoms: Injection site swelling, Nodule
Clinical narrative: Site: Swelling at Injection Site-Mild, Systemic: Nodule-Mild, Additional Details: got nodule right after administation, put ice at it at the phramacy, talked to patient same day at 5:30, all good, no worse or better but feeling fine
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Injection site pain, Mobility decreased
Clinical narrative: Site: Pain at Injection Site-Severe, Systemic: Joint Pain-Severe, Additional Details: Patient complains of shoulder pain severe enough that she cannot lift her arm. She claims the vaccine was administered high on the arm and to the back of the arm. However upon review of the video of administration, it appears the immunizer administered the vaccine in the right place.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Micturition urgency, Paranasal sinus discomfort, Tremor
Clinical narrative: Systemic: patient described as pressure in sinuses, and increased urge to go to the bathroom-Mild, Systemic: Shakiness-Mild
Age: 39.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Site: Redness at Injection Site-Medium, Site: Swelling at Injection Site-Medium
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site pain, Mobility decreased, Pain in extremity
Clinical narrative: Site: Pain at Injection Site-Severe, Additional Details: Arm still painful, having trouble lifting things.
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Dyspnoea exertional, Headache, Nausea, Pain
Clinical narrative: Day 1  (12 hrs after vaccine through about 8am the next day). Chills, fever (102), body aches, headache, nausea Day 2 ( headache, feeling exhausted) Symptoms would come and go Day 3  (headache, feeling winded when walking or exerting self)
Age: 59.0
Sex: F
Vaccine: VARZOS
Symptoms: Pyrexia
Clinical narrative: Day 1  (12 hrs after vaccine through about 8am the next day). Chills, fever (102), body aches, headache, nausea Day 2 ( headache, feeling exhausted) Symptoms would come and go Day 3  (headache, feeling winded when walking or exerting self)
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, COVID-19, Chills, Cough, Fatigue
Clinical narrative: 79-year-old male presents emergency department by EMS in no acute distress.  He was febrile.  He was diagnosed with COVID about a week ago and when his nurse came in and found that he had a fever sent to the ER for evaluation.  He was on steroids and antibiotics.  He states he has been coughing.  He is nontoxic in appearance.  No vomiting but he is producing sputum.  He also has a history of hypertension MI with stents diabetes. Associated Symptoms: chills, cough, fatigue, fever, sputum, weakness
Age: 78.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pneumonia, Productive cough, Pyrexia, SARS-CoV-2 test positive, White blood cell count normal
Clinical narrative: 79-year-old male presents emergency department by EMS in no acute distress.  He was febrile.  He was diagnosed with COVID about a week ago and when his nurse came in and found that he had a fever sent to the ER for evaluation.  He was on steroids and antibiotics.  He states he has been coughing.  He is nontoxic in appearance.  No vomiting but he is producing sputum.  He also has a history of hypertension MI with stents diabetes. Associated Symptoms: chills, cough, fatigue, fever, sputum, weakness
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Surgery, Syncope, Thrombosis
Clinical narrative: Blood clot caused collapse and when he was found he was sent to the Hospital where he died as a result
Age: 6.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered
Clinical narrative: Patient was given the 6mo-4yr dose. Provider spoke to the parent regarding the incorrect dose given. Did not re-dose at this visit. Will re-dose at the appropriate interval.
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Hyperhidrosis, Inflammation, Musculoskeletal stiffness, Osteoarthritis
Clinical narrative: extreme itching in the folds of the knees and elbows and wrists.  I also have sensitivity on my back,  it is exacerbated with heat and sweating ..   I also have developed osteoarthritis  requiring daily mediations for pain and stiffness.  I have been treated with prednisone, lortidine  and antiinflammatories  the vaccine has created an extreme inflammatory state in my body
Age: 67.0
Sex: M
Vaccine: COVID19
Symptoms: Pain, Pruritus, Sensitive skin, Skin test, Temperature intolerance
Clinical narrative: extreme itching in the folds of the knees and elbows and wrists.  I also have sensitivity on my back,  it is exacerbated with heat and sweating ..   I also have developed osteoarthritis  requiring daily mediations for pain and stiffness.  I have been treated with prednisone, lortidine  and antiinflammatories  the vaccine has created an extreme inflammatory state in my body
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Herpes zoster, Hypoaesthesia, Pain, Tenderness
Clinical narrative: Patient developed numbness, tenderness and pain left thoracic region radiating around to the front of chest on July 12 start mild very painful by July 15 and on July 16 Herpes Zoster rash present following the dermatone. We have photographs if needed
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Influenza like illness
Clinical narrative: On 12/31/21, after Pfizer booster, I experienced severe joint pain throughout my body.  In addition, I experienced flu-like symptoms.  Both of these symptoms occur every 2-3 weeks lasting 1-2 day.s
Age: 54.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, COVID-19, Transplant
Clinical narrative: Hospitalized for Acute Resp Failure due to COVID.  Transfer to  Hospital the following day due to patient being post transplant status.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature fluctuation, COVID-19, Cough, Diarrhoea, Headache
Clinical narrative: I started off with a deep chest cough. I had never had a fever, my temp fluctuates between 97 and 99 degrees. I have diarrhea on top of my other problem of diarrhea. I don't have a shortness breath but a heaviness of breath. The cough has lessened everyday. I was taking Mucinex with the pills for the first 3 days but stopped that yesterday because the cough wasn't severe enough. The first 3 days I had headaches that came and now have gone. I have a terrible taste in my mouth and had been drinking warm water with honey for 3 days, now have graduated to adding tea bags and now am able to get down regular water. I had a dull back pain near my rib cage and that's  come along. I was given paxlovid.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal chest pain, Pain, Respiration abnormal, SARS-CoV-2 test positive, Taste disorder
Clinical narrative: I started off with a deep chest cough. I had never had a fever, my temp fluctuates between 97 and 99 degrees. I have diarrhea on top of my other problem of diarrhea. I don't have a shortness breath but a heaviness of breath. The cough has lessened everyday. I was taking Mucinex with the pills for the first 3 days but stopped that yesterday because the cough wasn't severe enough. The first 3 days I had headaches that came and now have gone. I have a terrible taste in my mouth and had been drinking warm water with honey for 3 days, now have graduated to adding tea bags and now am able to get down regular water. I had a dull back pain near my rib cage and that's  come along. I was given paxlovid.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, COVID-19, Deafness, Ear discomfort, Erythema
Clinical narrative: All of suddenly, my face was turning red like burn, then my hands. I was holding my hand and my hand was burning, swollen, like a lobster. Similar reaction to a flu shot that I had before. I called the doctor and they told me if impact my breath go to the emergency room. I decided not to go since it wasn't that severe. Eventually it passed after 24 hours. At the end of May, I got COVID, I got a home test and it was positive. I was extremely exhausted, very thirsty, a lot of pressure on the ears and Sinus, lack of infection. The worst was my head congestion, loss of hearing because the pressure on the ears and I still have some caught periodically. Suddenly, my hands were shaking, my legs were shaking too and I collapsed over the floor. I had a nurse that comes to check me out but she said it was not a stroke, I had some sugar, some food, drink water and it took a while but by the next day I was okay.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nasal congestion, Paranasal sinus discomfort, Peripheral swelling, SARS-CoV-2 test positive
Clinical narrative: All of suddenly, my face was turning red like burn, then my hands. I was holding my hand and my hand was burning, swollen, like a lobster. Similar reaction to a flu shot that I had before. I called the doctor and they told me if impact my breath go to the emergency room. I decided not to go since it wasn't that severe. Eventually it passed after 24 hours. At the end of May, I got COVID, I got a home test and it was positive. I was extremely exhausted, very thirsty, a lot of pressure on the ears and Sinus, lack of infection. The worst was my head congestion, loss of hearing because the pressure on the ears and I still have some caught periodically. Suddenly, my hands were shaking, my legs were shaking too and I collapsed over the floor. I had a nurse that comes to check me out but she said it was not a stroke, I had some sugar, some food, drink water and it took a while but by the next day I was okay.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Syncope, Thirst, Tremor
Clinical narrative: All of suddenly, my face was turning red like burn, then my hands. I was holding my hand and my hand was burning, swollen, like a lobster. Similar reaction to a flu shot that I had before. I called the doctor and they told me if impact my breath go to the emergency room. I decided not to go since it wasn't that severe. Eventually it passed after 24 hours. At the end of May, I got COVID, I got a home test and it was positive. I was extremely exhausted, very thirsty, a lot of pressure on the ears and Sinus, lack of infection. The worst was my head congestion, loss of hearing because the pressure on the ears and I still have some caught periodically. Suddenly, my hands were shaking, my legs were shaking too and I collapsed over the floor. I had a nurse that comes to check me out but she said it was not a stroke, I had some sugar, some food, drink water and it took a while but by the next day I was okay.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Exposure to SARS-CoV-2, Fatigue, Respiratory tract congestion, Rhinorrhoea
Clinical narrative: I had a very sudden onset of symptoms of COVID-19. I was a first responder at the fair. I was leaving and the symptoms hit my like a ton of bricks. I had congestion and runny nose. It was like a bad cold. I found out some of my coworkers tested positive for  COVID-19. I tested at home and it was positive. The next day I contacted my doctor's office and it took them another day to get back to me. I was prescribed Paxlovid and within an hour of taking the first dose, I felt better. By the next day, my symptoms had diminished significantly. I did have some mild stomach issues and a metallic taste from the medication. The only symptom that lingered was fatigue. However, as of yesterday 07/17/2022 that fatigue is gone and I am testing negative. COVID-19 is very contagious. My wife caught it the day after I tested positive.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I had a very sudden onset of symptoms of COVID-19. I was a first responder at the fair. I was leaving and the symptoms hit my like a ton of bricks. I had congestion and runny nose. It was like a bad cold. I found out some of my coworkers tested positive for  COVID-19. I tested at home and it was positive. The next day I contacted my doctor's office and it took them another day to get back to me. I was prescribed Paxlovid and within an hour of taking the first dose, I felt better. By the next day, my symptoms had diminished significantly. I did have some mild stomach issues and a metallic taste from the medication. The only symptom that lingered was fatigue. However, as of yesterday 07/17/2022 that fatigue is gone and I am testing negative. COVID-19 is very contagious. My wife caught it the day after I tested positive.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: fully vaccinated covid positive pt admission to hospital
Age: 1.42
Sex: F
Vaccine: COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Rash/hives on torso
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive
Clinical narrative: Patient vaccinated against and then tested positive for COVID19.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Disorientation, Fatigue, Hyperhidrosis, Mobility decreased
Clinical narrative: Severe Chills Lasted two days  Facial Swelling Sweating lasted 3 days Severe Fatigue Entire Body to the point of not being able to get up from bed.  Lasted two Days some less on third and fourth day Disorientation lasted two days Blisters in upper part of mouth 2 days
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Oral mucosal blistering, Swelling face
Clinical narrative: Severe Chills Lasted two days  Facial Swelling Sweating lasted 3 days Severe Fatigue Entire Body to the point of not being able to get up from bed.  Lasted two Days some less on third and fourth day Disorientation lasted two days Blisters in upper part of mouth 2 days
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Fatigue, Headache, Injection site erythema, Injection site pain
Clinical narrative: Within 20 hours of receiving the Pfizer-BioNTech COVID-19 Vaccine EUA, I began experiencing the following symptoms: extreme fatigue headaches swelling, pain, and redness at injection site body aches  joint soreness  All these symptoms are continuing at 42 hours post vaccination.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling, Pain
Clinical narrative: Within 20 hours of receiving the Pfizer-BioNTech COVID-19 Vaccine EUA, I began experiencing the following symptoms: extreme fatigue headaches swelling, pain, and redness at injection site body aches  joint soreness  All these symptoms are continuing at 42 hours post vaccination.
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Asthenia, Blood glucose normal, Dizziness, Nausea, Pallor
Clinical narrative: This patient was seen today in office for vaccines pt got tdap, hpv, meningitis vaccine. After the vaccines were given the patient began to feel nausea, dizzy, weak & and "hot on her back". We went to get staff. We noticed that she was pale we took he bp and bs. Her blood sugar was 89 NF and her bp 77/39. Staff thinks it could possibly be vasovagal. Could you run this by Dr  if she would need any further testing before she continues any further vaccines series.
Age: 11.0
Sex: F
Vaccine: HPV9, MNQ, TDAP
Symptoms: Skin warm
Clinical narrative: This patient was seen today in office for vaccines pt got tdap, hpv, meningitis vaccine. After the vaccines were given the patient began to feel nausea, dizzy, weak & and "hot on her back". We went to get staff. We noticed that she was pale we took he bp and bs. Her blood sugar was 89 NF and her bp 77/39. Staff thinks it could possibly be vasovagal. Could you run this by Dr  if she would need any further testing before she continues any further vaccines series.
Age: 85.0
Sex: U
Vaccine: UNK
Symptoms: COVID-19
Clinical narrative: Pt diagnosed and admitted with Covid.  Pt received Covid Vaccine
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Abulia, Acute respiratory failure, Angiogram normal, COVID-19, Computerised tomogram head normal
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 7/10/2022 Discharge Date: Jul 11, 2022   PRESENTING PROBLEM: Hypoxia [R09.02] Laceration of left eyebrow, initial encounter [S01.112A] Blunt head trauma, initial encounter [S09.8XXA] Fall from ground level [W18.30XA] Acute hypoxemic respiratory failure (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE:   "Patient is a 77 yo male with a PMHx of chronic obstructive pulmonary disease, prostate cancer in 2007 s/p radiation, hypothyroidism, osteoporosis on Prolia who presented after a fall from ground level height.  Patient states that he was going for a walk and tripped when he fell into some bushes and hit his head on the ground. Noted patient is not on blood thinners but is on aspirin daily. He did not lose consciousness. He does not remember the events clearly. Bystanders who witnessed the fall helped him stand up called EMS. Patient states that prior to the fall he had no symptoms and was healthy. He is unsure if he had been around any sick contacts. He does not wear O2 at baseline and states that he lives alone. He states that prior to the fall he can usually remember his medications but is unable to at this time.    In the emergency department patient noted to be hypoxic requiring 4 L of supplemental oxygen.  CT of the head, CT cervical spine negative for acute findings.  Tetanus shot was updated due to a laceration to his lateral orbit which was repaired.  COVID-19 noted to be positive.  CT angiogram negative for any acute findings.  Labs unremarkable except for hemoglobin at 12.3.    Spoke with family upon patients permission who stated that patient has an "odd" personality but they did not feel he is usually confused at baseline. They did state that he will go back and forth with decisions frequently or never give a for sure answer. They were unaware of his PMHx or current medications as patient lived alone"   Patient was weaned off of oxygen overnight. He was seen by PT and OT who recommended home with home health care services. Patient was sent home with 8 more days of decadron for COVID-19 infection.
Age: 77.0
Sex: M
Vaccine: COVID19
Symptoms: Computerised tomogram spine, Condition aggravated, Fall, Gait disturbance, Haemoglobin decreased
Clinical narrative: Discharge Provider: MD Primary Care Provider: DO Admission Date: 7/10/2022 Discharge Date: Jul 11, 2022   PRESENTING PROBLEM: Hypoxia [R09.02] Laceration of left eyebrow, initial encounter [S01.112A] Blunt head trauma, initial encounter [S09.8XXA] Fall from ground level [W18.30XA] Acute hypoxemic respiratory failure (HCC) [J96.01] COVID-19 [U07.1]   HOSPITAL COURSE:   "Patient is a 77 yo male with a PMHx of chronic obstructive pulmonary disease, prostate cancer in 2007 s/p radiation, hypothyroidism, osteoporosis on Prolia who presented after a fall from ground level height.  Patient states that he was going for a walk and tripped when he fell into some bushes and hit his head on the ground. Noted patient is not on blood thinners but is on aspirin daily. He did not lose consciousness. He does not remember the events clearly. Bystanders who witnessed the fall helped him stand up called EMS. Patient states that prior to the fall he had no symptoms and was healthy. He is unsure if he had been around any sick contacts. He does not wear O2 at baseline and states that he lives alone. He states that prior to the fall he can usually remember his medications but is unable to at this time.    In the emergency department patient noted to be hypoxic requiring 4 L of supplemental oxygen.  CT of the head, CT cervical spine negative for acute findings.  Tetanus shot was updated due to a laceration to his lateral orbit which was repaired.  COVID-19 noted to be positive.  CT angiogram negative for any acute findings.  Labs unremarkable except for hemoglobin at 12.3.    Spoke with family upon patients permission who stated that patient has an "odd" personality but they did not feel he is usually confused at baseline. They did state that he will go back and forth with decisions frequently or never give a for sure answer. They were unaware of his PMHx or current medications as patient lived alone"   Patient was weaned off of oxygen overnight. He was seen by PT and OT who recommended home with home health care services. Patient was sent home with 8 more days of decadron for COVID-19 infection.